Fees and Royalties. In partial consideration for the rights granted herein, Licensee will pay to ULRF the fees, royalties and other amounts specified in Exhibit B, and will reimburse ULRF for costs incurred in connection with the Licensed Patents as provided in Section 9.2.
Appears in 3 contracts
Sources: Exclusive License Agreement (Qualigen Therapeutics, Inc.), Exclusive License Agreement (Qualigen Therapeutics, Inc.), Exclusive License Agreement (Ritter Pharmaceuticals Inc)
Fees and Royalties. In partial consideration for the rights granted herein, Licensee will pay to ULRF the fees, royalties and other amounts specified in Exhibit B, and will reimburse ULRF for costs incurred in connection with the Licensed Patents as provided in Section 9.2.
Appears in 2 contracts
Sources: Exclusive License Agreement (Talaris Therapeutics, Inc.), Exclusive License Agreement (Talaris Therapeutics, Inc.)
Fees and Royalties. In partial As additional consideration for the rights granted herein, Licensee will pay to ULRF the fees, royalties and other amounts specified in Exhibit B, and will reimburse ULRF for costs incurred in connection with the Licensed Patents and Licensed Copyrights as provided in Section 9.2Article 9.
Appears in 2 contracts
Sources: Exclusive License Agreement (Neuro Spectrum Insights, Inc.), Exclusive License Agreement (Neuro Spectrum Insights, Inc.)